Stock overview
Bioxcel Therapeutics Inc.
Explore the company, reported ownership, price history, and available source evidence.
BIOXCEL THERAPEUTICS INC (BTAI) is a healthcare or biotechnology equity security tracked from 13F filings.
- Last close
- $0.04
- · BTAI
- Tracked holders
- 1 fund
- Latest available 13F per fund
BTAI · USD
Price
$0.04
-$3.13
(-98.59%)
over selected range
Close · Sep 15, 2026
Market closed
233 stored daily closes
$0.04
Sep 15, 2026
- Range low
- $0.04
- Range high
- $3.17
- Observations
- 233
- Session date
- Sep 15, 2026
Sep 15, 2025–Sep 15, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Oaktree Capital Management largest tracked holder Q2 2026 · filed Aug 14, 2026 · SEC filing | +472% 26'Q2 | $1,946,150 | 0.03% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market